Polycystic kidney disease (PKD) is a genetic disorder marked by the growth of many fluid-filled sacs (cysts) in your kidneys. These cysts can grow to replace normal kidney tissue over time, leading to ...

Please provide your email address to receive an email when new articles are posted on . Tolvaptan treatment correlated with a slowed annual rate of GFR decline in this population. Tolvaptan may ...

In this free webinar, gain insight into the main challenges in patient recruitment for autosomal dominant polycystic kidney disease (ADPKD) clinical trials. Attendees will learn about the clinical ...

Polycystic kidney disease (PKD) is a debilitating hereditary condition in which fluid-filled sacs form and proliferate in the kidneys. Over time, the ...

A study of kidney organoids in a novel lab environment might have downstream implications for the treatment of polycystic kidney disease (PKD), an incurable condition that affects more than 12 million ...

Please provide your email address to receive an email when new articles are posted on . Of the included patients, 2.5% were on dialysis and 23% had a kidney transplant. Autosomal dominant PKD affects ...

Chronic pain is a common challenge when you have autosomal dominant polycystic kidney disease (ADPKD). But there are many treatment options to help you manage your pain and other symptoms so you can ...

Patient recruitment is underway for a University of Queensland-led clinical trial to test the effectiveness of a diabetes drug to slow the progression of polycystic kidney disease (PKD). Study-lead ...

Scientists have initiated a study to investigate whether dapagliflozin, an already approved drug from the SGLT2 inhibitors group, can positively affect the course of autosomal dominant polycystic ...

A cheap, safe and effective treatment to polycystic kidney disease may soon be available, thanks to a new national clinical out of Westmead, Australia, which is trialing water to treat the disease.

"Autosomal Dominant Polycystic Kidney Disease Treatment Market"Autosomal Dominant Polycystic Kidney Disease Companies are Otsuka America Pharmaceuticals, Vertex Pharmaceuticals, Pfizer, Otsuka Pharma, ...